171 related articles for article (PubMed ID: 3872691)
41. Evaluation of assays to detect immune complexes as an immunodiagnostic aid in patients with melanoma.
Ruell P; Murray E; McCarthy WH; Hersey P
Oncodev Biol Med; 1982; 3(1):1-12. PubMed ID: 6981802
[TBL] [Abstract][Full Text] [Related]
42. Loss of suppressor T cell function and circulating immune complexes in alcoholic cirrhosis.
Echevarría S; San Miguel G; Rodríguez de Lope C; Castillo E; Pons Romero F
Allergol Immunopathol (Madr); 1985; 13(5):405-10. PubMed ID: 2934964
[TBL] [Abstract][Full Text] [Related]
43. Circulating immune complexes in patients with rheumatoid arthritis: correlation with disease activity.
Levo Y; Fischel R; Ehrenfeld M
J Rheumatol; 1981; 8(5):851-5. PubMed ID: 7310781
[TBL] [Abstract][Full Text] [Related]
44. [An immunological study of endogenous uveitis: circulating immune complexes and their specific characteristics].
Zhang MD; Huang SR
Zhonghua Yan Ke Za Zhi; 1991 Jul; 27(4):231-4. PubMed ID: 1935452
[TBL] [Abstract][Full Text] [Related]
45. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.
Müller V; Stahmann N; Riethdorf S; Rau T; Zabel T; Goetz A; Jänicke F; Pantel K
Clin Cancer Res; 2005 May; 11(10):3678-85. PubMed ID: 15897564
[TBL] [Abstract][Full Text] [Related]
46. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
47. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
48. Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.
Hayes DF; Yamauchi H; Broadwater G; Cirrincione CT; Rodrigue SP; Berry DA; Younger J; Panasci LL; Millard F; Duggan DB; Norton L; Henderson IC;
Clin Cancer Res; 2001 Sep; 7(9):2703-11. PubMed ID: 11555582
[TBL] [Abstract][Full Text] [Related]
49. Circulating IgA immune complexes in patients with psoriasis.
Hall RP; Peck GL; Lawley TJ
J Invest Dermatol; 1983 Jun; 80(6):465-8. PubMed ID: 6602187
[TBL] [Abstract][Full Text] [Related]
50. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
51. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
[TBL] [Abstract][Full Text] [Related]
52. [Isolation and characterization of immune complexes associated with malignant tumors and leprosy].
Segal-Eiras A; Croce MV; Ramos GS; Córsico B
Medicina (B Aires); 1989; 49(2):125-30. PubMed ID: 2640480
[TBL] [Abstract][Full Text] [Related]
53. Circulating immune complexes in Behçet's disease.
Inoue T; Oniki S; Kajiyama K; Jimi S
Jpn J Ophthalmol; 1983; 27(1):35-9. PubMed ID: 6602236
[TBL] [Abstract][Full Text] [Related]
54. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
[TBL] [Abstract][Full Text] [Related]
55. Circulating immune complexes in acute leukemia.
Cermák J; Feyereislová A; Horejsí J
Neoplasma; 1989; 36(1):21-7. PubMed ID: 2704422
[TBL] [Abstract][Full Text] [Related]
56. [Circulating immune complexes and immunologic reactivity in breast cancer].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
[TBL] [Abstract][Full Text] [Related]
57. [Circulating immune complex (CIC) and antitumor antibody in the serum of rats with thyroid carcinoma induced by 132I].
Hou JC
Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):173-5. PubMed ID: 3743342
[TBL] [Abstract][Full Text] [Related]
58. [Clinical significance of the level of circulating immune complexes in patients with small cell bronchial carcinoma].
Malberg K; Prokop D; von Paris V
Allerg Immunol (Leipz); 1990; 36(4):287-92. PubMed ID: 1965877
[TBL] [Abstract][Full Text] [Related]
59. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
Brandeis WE; Tan C; Wang Y; Good RA; Day NK
Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
[TBL] [Abstract][Full Text] [Related]
60. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients.
Das S
Arch Geschwulstforsch; 1987; 57(4):283-6. PubMed ID: 3675140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
